Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tofacitinib ameliorates Campylobacter-induced intestinal pathology by suppressing IFNγ producing ILCs and T cells

Mucosal Immunology(2025)10.1016/j.mucimm.2025.06.010Source: DataRank Database

Tofacitinib ameliorates Campylobacter-induced intestinal pathology by suppressing IFNγ producing ILCs and T cells is a research paper published in Mucosal Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 0.36)OA: hybridTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Sergey A. Shein,Wayne T. Muraoka ORCID,Justin Nguyen ORCID,Q. Chen,Anna A Tumanova

Live enrichment

PubMed:40614970 PMC:PMC12431686 OpenAlex:https://openalex.org/W4411982552

National Institutes of Health

Grant: AI105813

National Institutes of Health

Grant: AI161400

National Institutes of Health

Grant: AI173816

National Cancer Institute

Grant: RP210126

National Cancer Institute

Grant: 1S10OD030432

National Cancer Institute

Grant: P30CA054174

Cancer Prevention and Research Institute of Texas

Grant: RP210105

Cancer Prevention and Research Institute of Texas

Grant: RP220470

Pfizer

Grant: WI215053

National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Grant: AI135574

National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Grant: AI167416

NIGMS NIH HHS

Grant: T32 GM113896

NIAID NIH HHS

Grant: R01 AI105813

NIAID NIH HHS

Grant: R01 AI167416

NIAID NIH HHS

Grant: R21 AI173816

NIAID NIH HHS

Grant: R56 AI105813

NIAID NIH HHS

Grant: R21 AI135574

NIAID NIH HHS

Grant: R21 AI161400

NIH HHS

Grant: S10 OD030432

NIGMS NIH HHS

Grant: T32 GM145432

FWCI

0.36

Citation Percentile

0.6%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.mucimm.2025.06.010

publisherhttps://doi.org/10.1016/j.mucimm.2025.06.010

publisherhttps://api.elsevier.com/content/article/PII:S1933021925000704?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1933021925000704?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40614970

Fields of Study

IL-33, ST2, and ILC PathwaysEosinophilic EsophagitisViral gastroenteritis research and epidemiologyAnimalsPyrimidinesPiperidinesMiceInterferon-gammaHumansT-LymphocytesDisease Models, AnimalCampylobacter InfectionsCampylobacter jejuniLymphocytesImmunity, InnateMice, Inbred C57BLIntestinal MucosaIntestinesSignal TransductionProtein Kinase Inhibitors

MeSH Terms

AnimalsCampylobacter InfectionsDisease Models, AnimalHumansImmunity, InnateInterferon-gammaIntestinal MucosaIntestinesLymphocytesMice, Inbred C57BLPiperidinesPyrimidinesT-LymphocytesSignal TransductionCampylobacter jejuniProtein Kinase InhibitorsMice

Keywords

TofacitinibInnate lymphoid cellImmunologyProinflammatory cytokineRAR-related orphan receptor gammaMedicineInterleukin 22ColitisBiologyCytokineInnate immune systemInflammationImmune systemInterleukinFOXP3Rheumatoid arthritisCampylobacter jejuniInfectious ColitisJak/statInnate Lymphoid Cells

Sustainable Development Goals

SDG 0: Zero hunger